Novartis brings pioneer online medical platform to Vietnam
November 18, 2020 | 10:30
Aiming to offer an exclusive digital network for medical staff, Novartis Vietnam Ltd. has recently teamed up with Docquity Holdings Pte., Ltd. to bring the Docquity online platform to Vietnam.
Russian firms urged to set up pharmaceutical ventures in Vietnam: meeting
July 12, 2020 | 16:18
Russia’s pharmaceutical companies should consider setting up ventures in Vietnam instead of only focusing on exports, heard a virtual meeting held on July 10 on potential for the Vietnam-Russia trade and economic cooperation after the COVID-19 pandemic.
Pharmaceutical groups yearn for end to VAT tangle
July 08, 2020 | 12:11
Amidst lingering complaints from businesses on VAT for imported medical devices, the Ministry of Finance has broken its silence by announcing the ongoing revision of prevailing rules, but tangled inconsistencies will remain with no timeline yet revealed.
Novartis agrees to $642mn US settlement over kickbacks
July 02, 2020 | 10:14
Swiss pharmaceutical giant Novartis has agreed to pay more than $642 million to settle a lawsuit which accused it of paying kickbacks to doctors, among other allegations, the US Department of Justice said Wednesday.
Gradual but radical changes set to sweep pharmaceutical landscape
May 30, 2020 | 08:00
The upcoming implementation of the EU-Vietnam Free Trade Agreement (EVFTA) is expected to transform the competitive landscape of Vietnam’s pharmaceutical and medical industry.
Lucrative opportunities amid crisis
March 25, 2020 | 11:00
The pharmaceutical and healthcare industry is creating new medical and biotech billionaires in Vietnam, putting the country on the global map of breakthrough medical advances.
Pharma chiefs expect coronavirus vaccine in 12-18 months
March 20, 2020 | 15:45
The pharmaceutical industry expects it will take 12 to 18 months to roll out a coronavirus vaccine, executives said on Thursday (Mar 19), as they jointly pledged to make it available worldwide based on need.
Pharma initiatives to cure the needy
February 28, 2020 | 12:00
Multinational pharmaceutical groups are seeking ways to support Vietnamese in accessing medical services, and widen their market share in the country in the face of drastic competition.
Big players join hands in national epidemic prevention campaign
February 26, 2020 | 09:00
The threat caused by the novel coronavirus outbreak has been partly relieved with the engagement of leading prestigious players from the pharmaceutical industry, such as Traphaco.
Imexpharm continues to push limits of possibility
February 24, 2020 | 14:00
As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
Pharma giants seek to cash in on local market potential
February 15, 2020 | 13:00
While several sectors are being hit by the coronavirus outbreak in Vietnam, the pharmaceutical and healthcare industry is taking an advantage, with numerous expansion strategies among players being placed in the gun barrel.
Developing smart healthcare systems
January 25, 2020 | 16:00
In line with Vietnam’s smart healthcare development scheme by 2025, domestic pharmaceutical giants are burning into sci-tech, while multinational corporations are venturing further into grassroots healthcare to tap into growing high-quality demand.
Sapharco asked to revoke Korean-imported Young II Captopril tablet
November 28, 2019 | 15:00
The DAV has ordered the suspension of Young II Captopril Tablet of South Korea’s Young IL Pharm. Co., Ltd for failing to meet quality standards.
Leading pharma firm fined for securities-related violations
November 04, 2019 | 12:24
Danapha has been fined for over VND500 million ($21,740) for securities-related violations, according to the State Securities Commission of Vietnam.
Local pharma dives into ethical drugs
September 12, 2019 | 14:00
Facing much tougher competition ahead, Vietnamese big pharmaceutical firms are seeking new solutions in order to delve deeper into the ethical drugs channel to shore up growth. However, creating and implementing such solutions will not be smooth sailing. Bich Thuy reports.
Mobile Version